Uses of north american ginseng fractions for treating leukemia

摘要

The invention is directed to a method of treating hematological malignancies byadministering to the subject ginseng fractions from North American ginseng (Panaxquinquefolium). The present invention can be used to activate the proliferation ofhemopoietic cells in a patient in need of treatment, or as a therapeutic targeted atconditions characterized by hematological malignancy, such as an abnormal proliferationof blood cells, lymphocytes, multiple myeloma, etc. The invention also includesa method of treating leukemia by activating the proliferation of natural killer(NK) cells and monocytes in the bone marrow and the spleen of the patient by administeringat least one ginseng fraction selected from the group consisting of CVT-E002,PQ